Skip to main content

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Completed · Phase 3 · NCT05139121

Conditions: Contraception

At a glance

Research payments reported, 2025
$2.0M
U.S. investigators named
69
Sites paid
61
Planned or actual enrollment
1,320

About the trial

Sponsor
Mylan Technologies Inc. (with Mylan Inc.)
Tested
MR-100A-01 (drug)
Dates
Started 2021-10-26; completion 2025-01-15
Results posted
Yes

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

From ClinicalTrials.gov, last updated 2026-09-14. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Mylan Inc. reported $2.0M in research payments for this study in 2025 (346 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Research Centers of America, LLC $475,710
  • Cenexel Iresearch, LLC $311,138
  • Affiliated Clinical Research Inc $97,808
  • Cedar Health Research LLC $91,803
  • Trustees of Columbia University $76,393
  • Essential Access Health $70,885
  • Cactus Clinical Research Inc $64,526
  • Quantum Clinical Trials $64,076
  • Velocity Clinical Research Inc $53,082
  • Precision Trials Az LLC $52,889
  • Clinical Trials Management LLC $45,874
  • New Age Medical Research Corporation $37,999
  • Admed Research LLC $34,298
  • Seattle Crc LLC $32,245
  • Physician Care Clinical Research LLC $24,213
  • Amicis Research Center $22,125
  • Javara Inc $21,361
  • Cedar Health Research Inc $19,779
  • Orca Trial LLC $18,578
  • Alliance Research Institute $18,500
  • Wr Crcn LLC $17,945
  • Northern California Research $17,629
  • Clinical Trial Source $16,918
  • Tidewater Clinical Research Inc $15,992
  • M3 Wake Research Inc $15,965
  • Suncoast Clinical Research LLC $15,128
  • Puerto Rico Medical Research Inc $13,556
  • Chattanooga Medical Research LLC $13,032
  • Intimmedicinespecialists $12,884
  • Wr Women S Health Care Research LLC $11,454
  • Board of Trustees of the Leland Stanford Junior University $11,354
  • University Hospitals Cleveland Medical Center $10,174
  • Oregon Health and Science University $9,962
  • Wr-Mount Vernon Clinical Research LLC $9,414
  • Dct Hcwc LLC DBA Discovery Clinical Trials $9,296
  • The Trustees of the University of Pennsylvania $9,034
  • $8,810
  • Matrix Clinical Research Inc $8,646
  • Clinical Research Philadelphia LLC $8,531
  • Advanced Pharma Cr LLC $7,636
  • Advances in Health Inc $7,615
  • Texas Center for Drug Development Inc $7,153
  • University of Florida $7,125
  • Clintheory Healthcare Miami $6,725
  • Lawrence D Platt MD Inc $6,500
  • Fellows Research Alliance Inc $6,298
  • Cr Services Acquisition US LLC $5,614
  • Altus Clinical Research LLC $5,255
  • Quantum Clinical of Dade County $4,322
  • Planned PArenthood North Central States $4,100
  • Unified Women S Clinical Research $4,000
  • Wasatch Clinical Research $4,000
  • Healthcare Clinical Data Inc $3,499
  • Praetorian Pharmaceutical Research LLC $3,444
  • Global Health Research Center $3,275
  • Carolina Women's Research and Wellness Center $2,255
  • Old Dominion University Research Foundation $1,999
  • University of Pittsburgh Physicians $1,852
  • Agile Clinical Research Trials LLC $1,665
  • Upstate Clinical Research Associates LLC $1,351
  • Wrmsrallc $400
  • Sbl Special Services LLC $90

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.